FDA Clears New Disposable Insulin Patch Pump For Patients With T1D and T2D
Drug Topics
SEPTEMBER 4, 2024
Embecta’s new patch pump offers a larger insulin reservoir to better accommodate for the needs of patients with type 2 diabetes (T2D).
Sat.Aug 31, 2024 - Fri.Sep 06, 2024
200 
New Perspectives in CML Management: Personalized Approaches and Adaptive Strategies
Pharmacy Times
SEPTEMBER 5, 2024
Optimizing outcomes for patients with chronic myeloid leukemia (CML) requires personalized treatment, adaptive dosing, and precise genetic insights.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Missouri resident who had no contact with animals tests positive for bird flu
STAT
SEPTEMBER 6, 2024
This is a developing story and will be updated. A person in Missouri who didn’t report any contact with animals has tested positive for H5 bird flu, the state’s Department of Health and Senior Services and the Centers for Disease Control and Prevention said Friday. It’s not yet clear if the person was infected with the same virus strain that’s causing the ongoing outbreak among dairy cattle.
AstraZeneca staffers detained in China over patient data collection, drug imports: Bloomberg
Fierce Pharma
SEPTEMBER 5, 2024
AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case. | AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Clears First Digital Therapeutic for Treatment of Generalized Anxiety Disorder
Drug Topics
SEPTEMBER 4, 2024
DaylightRX from Big Health is a digital formulation of cognitive behavioral therapy and is available by prescription only.
Tolebrutinib Shows Reduction in Disability Accumulation in Non-Relapsing Secondary Progressive Multiple Sclerosis
Pharmacy Times
SEPTEMBER 4, 2024
In a promising development in multiple sclerosis research, tolebrutinib delayed the onset of disability progression in patients with nrSPMS.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
SCAN embraces 'rebels with a cause' founding in new brand identity
Fierce Healthcare
SEPTEMBER 5, 2024
SCAN Group is refreshing its visual identity, building its new look around honoring the "rebels with a cause" that founded the company and who continue to inspire its work. | SCAN Group is refreshing its visual identity, building its new look around honoring the "rebels with a cause" that founded the company and who continue to inspire its work.
FDA Roundup: Novavax COVID-19 Vaccine, First Digital Therapeutic for GAD
Drug Topics
SEPTEMBER 6, 2024
Check out important updates from the FDA for the week of September 2.
Pharmacists Can Counsel Pregnant Individuals Seeking Iron Supplementation
Pharmacy Times
SEPTEMBER 5, 2024
There is no significant impact on maternal or infant health outcomes when taking an additional iron supplement
Trying to time your seasonal vaccines just right? There are no easy answers, but here are some factors to consider
STAT
SEPTEMBER 4, 2024
With fall coming into view, public health officials across the country are turning to the annual task of persuading legions of Americans to get vaccinated against some combination of influenza, Covid-19, and respiratory syncytial virus, three bugs that sicken mass numbers of people over the winter months, often overwhelming hospitals and health care delivery in the process.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
China detains AstraZeneca workers in data, imports probe
pharmaphorum
SEPTEMBER 5, 2024
A "small number" of AstraZeneca employees have been detained in China in an investigation into suspected data privacy and drug import breaches
NCPA Calls on CMS to Establish PBM Protection for Independent Pharmacies
Drug Topics
SEPTEMBER 5, 2024
As Medicare open enrollment begins, the NCPA is urging CMS to facilitate appropriate PBM contracting for pharmacies in the upcoming plan year.
FDA Approves Sparsentan, With Data Indicating Slowing of Kidney Function Decline in IgA Nephropathy
Pharmacy Times
SEPTEMBER 6, 2024
Full traditional approval follows accelerated approval of the medication last year.
Doctors use problematic race-based algorithms to guide care every day. Why are they so hard to change?
STAT
SEPTEMBER 3, 2024
Pediatrician Alexandra Epee-Bounya had had enough. In her 20 years caring for children in Boston, she had seen hundreds of kids with suspected urinary tract infections. Each time, she’d turn to a calculator, used by all Boston Children’s Hospital clinicians, to judge the youngest childrens’ risk. Did the infant have a high fever?
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
American Medical Association slams pay cut, G-codes in proposed Medicare pay rule for doctors
Fierce Healthcare
SEPTEMBER 6, 2024
In its comments to the Centers for Medicare and Medicaid Services (CMS) on the draft CY2025 Medicare physician fee schedule (PFS), the American Medical Association badgered CMS on its pro | The American Medical Association submitted its comment letter to CMS on its draft CY2025 Medicare physician fee schedule. At issue was the 2.
Immunization Roundup: Updated COVID-19 Vaccines, Mpox Approval, and More
Drug Topics
SEPTEMBER 2, 2024
Catch up on important immunization news from the month of August.
Study: Shingles Could Increase Risk of Cognitive Decline
Pharmacy Times
SEPTEMBER 6, 2024
Individuals with a history of shingles was significantly and independently connected with a 20% higher risk of for subjective cognitive decline.
Opinion: Letting funding for the All of Us research program lapse will cost the U.S. far more than it saves
STAT
SEPTEMBER 3, 2024
I was in high school when I first encountered the ruthlessness of the number one killer in the U.S. A close friend of mine, then only 16 years old, witnessed his father having a heart attack while checking the mail. Despite desperate attempts at CPR on the driveway, he wasn’t able to save his dad, a seemingly healthy man in his early 40s. That event put me on a path to become a cardiologist.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Providers, vendors building health AI have 'shared responsibility' to ensure safe adoption industrywide
Fierce Healthcare
SEPTEMBER 6, 2024
BOSTON—There’s no shortage of providers and vendors working to develop and deploy artificial intelligence in healthcare—but not all who are delivering care are in a position to make use of these no | Healthcare AI has a tough battle on adoption, trust and responsible use, particularly among organizations lacking in-house tech expertise. Whether it's a vendor or another health system, stakeholders must be prepared to help their peers along the way, experts say.
The Unyielding Grip of Fentanyl on America's Streets: A Pharmacist's Perspective
Drug Topics
SEPTEMBER 3, 2024
Independent pharmacists, health care providers, community leaders, and law enforcement must all work together to address the fentanyl epidemic.
IVIG Shows Promise as Therapy in Patients With Recurrent Implantation Failure
Pharmacy Times
SEPTEMBER 5, 2024
Intravenous immunoglobulin (IVIG) therapy was found to have statistically significant positive effects on live birth rates, implantation rate, and other indicators.
STAT+: Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades
STAT
SEPTEMBER 3, 2024
Kathy Giusti was diagnosed with multiple myeloma in 1996, when she was a 37-year-old executive at the drug company G.D. Searle. She was told she had three years to live. Twenty-eight years later, Giusti, 65, is thriving. One reason is the patient advocacy group she founded in 1998: the Multiple Myeloma Research Foundation. The group has raised more than $600 million for research, launched nearly 100 clinical trials, and helped bring more than 15 new drugs to market.
Thatch secures $38M, backed by a16z and General Catalyst, to expand ICHRA benefits
Fierce Healthcare
SEPTEMBER 6, 2024
Thatch wants to turn the traditional approach to health insurance on its head. | Thatch wants to turn the traditional approach to health insurance on its head. The company secured $38 million, backed by a16z and General Catalyst, to scale up its technology and fuel its growth.
FDA Approves Updated Novavax COVID-19 Vaccine
Drug Topics
SEPTEMBER 3, 2024
The protein-based vaccine includes a monovalent component corresponding to the Omicron variant JN.1 strain.
Staying Up to Date With Routine Vaccinations is Crucial to Slowing Spread, Expert Says
Pharmacy Times
SEPTEMBER 5, 2024
Lauren Posteraro, PharmD, a pharmacist with AHN, discusses how misinformation and access to technology can contribute to vaccine hesitancy.
Moderna reports encouraging results on its mpox vaccine, as outbreaks in Africa spread
STAT
SEPTEMBER 4, 2024
The emergence of a second mpox outbreak in which the virus is spreading from person-to-person, as well as a sharp increase in overall cases of the disease in several African countries, is straining the world’s capacity to make and distribute vaccine to battle the threat. New options are needed, and a study published Wednesday suggests another may be on the horizon.
Industry Voices—Strategies to stem losses of America's primary care doctors
Fierce Healthcare
SEPTEMBER 5, 2024
Charles Jantzen, M.D., found himself swept up in the same current so many newly trained family physicians are in upon graduating from residency: employed by the health system where he previously tr | There is no single solution to this primary care shortage. Its complex drivers both shrink the entry pipeline and increase the terminal exodus.
Abbott’s OTC Lingo CGM for Wellness Now Available
Drug Topics
SEPTEMBER 6, 2024
Lingo offers users a real-time glucose graph, a metric to track glucose spikes, food and activity logging, personal recommendations, and challenges to motivate healthy behaviors.
CDC Recommends Preventative Action Amid Rising Cases of West Nile Virus
Pharmacy Times
SEPTEMBER 2, 2024
Cases have been detected in 33 US states so far this year, and the virus has recently hospitalized the former Chief Medical Advisor to the President of the US Anthony Fauci.
STAT+: Vor Biopharma’s ‘shielded’ transplant delays relapse in leukemia patients
STAT
SEPTEMBER 5, 2024
A CRISPR-augmented stem cell transplant that protects healthy cells from the toxic effects of anti-cancer medicines has shown preliminary evidence that it can delay relapse in patients with an aggressive form of leukemia, its maker Vor Biopharma said Thursday. In the early stage study, eight of 10 patients with high-risk acute myeloid leukemia remain in remission after receiving a transplant with the Vor therapy, called trem-cel, followed by maintenance treatment with intensified doses of
In Europe, shortages of Novo Nordisk's Ozempic to persist into Q4: letter
Fierce Pharma
SEPTEMBER 3, 2024
Late last year, Novo Nordisk responded to a growing shortage of popular Ozempic with a plan to cut down on production of its older diabetes med Victoza to make room for more Ozempic. | The company and the European Medicines Agency warned European healthcare providers to continue limiting new patient prescriptions until the shortages let up.
Community Pharmacist-Led Intervention for Victims of Domestic Abuse, Suicidal Ideation
Drug Topics
SEPTEMBER 6, 2024
Researchers analyzed a co-developed pharmacy-based intervention for individuals who have experienced domestic abuse or suicidal ideation.
FDA Authorizes New Drug Application For Trial to Evaluate Treatment for Long COVID
Pharmacy Times
SEPTEMBER 3, 2024
Bezisterim, an anti-inflammatory insulin sensitizer, will be authorized to proceed to a phase 2 clinical trial.
Let's personalize your content